![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 39, 35783-35786, September 27, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
From the Manitoba Institute of Cell Biology, Winnipeg,
Manitoba R3E 0V9, Canada, Sp1 and Sp3 are ubiquitously expressed mammalian
transcription factors that function as activators or repressors.
Although both transcription factors share a common domain involved in
forming multimers, we demonstrate that Sp1 and Sp3 form separate
complexes in estrogen-dependent human breast cancer cells.
Sp1 and Sp3 complexes associate with histone deacetylases (HDACs) 1 and
2. Although most HDAC2 is not phosphorylated in the breast cancer
cells, HDAC2 bound to Sp1 and Sp3 and cross-linked to chromatin
in situ is highly enriched in a phosphorylated form that
has a reduced mobility in SDS-polyacrylamide gels. We show that protein
kinase CK2 is associated with and phosphorylates HDAC2. Alkaline
phosphatase treatment of HDAC2 and Sp1 and Sp3 complexes reduced the
associated HDAC activity. Protein kinase CK2 is up-regulated in several
cancers including breast cancer, and Sp1 and Sp3 have key roles in
estrogen-induced proliferation and gene expression in
estrogen-dependent breast cancer cells. CK2 phosphorylation
of HDAC2 recruited by Sp1 or Sp3 could regulate HDAC activity and alter
the balance of histone deacetylase and histone acetyltransferase
activities and dynamic chromatin remodeling of estrogen-regulated genes.
Department of Biochemistry,
University of Western Ontario, London, Ontario N6A 5C1, Canada, and
§ H. Lee Moffitt Cancer Center and Research Institute,
University of South Florida, Tampa, Florida 33612
This article has been cited by other articles:
![]() |
J.-M. Sun, H. Y. Chen, and J. R. Davie Differential Distribution of Unmodified and Phosphorylated Histone Deacetylase 2 in Chromatin J. Biol. Chem., November 9, 2007; 282(45): 33227 - 33236. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Almeida, Y. Murakami, A. Baker, Y. Maeda, I. A.G. Roberts, T. Kinoshita, D. M. Layton, and A. Karadimitris Targeted Therapy for Inherited GPI Deficiency N. Engl. J. Med., April 19, 2007; 356(16): 1641 - 1647. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Liu, N. Pore, M. Kim, K. R. Voong, M. Dowling, A. Maity, and G. D. Kao Regulation of Histone Deacetylase 4 Expression by the SP Family of Transcription Factors Mol. Biol. Cell, February 1, 2006; 17(2): 585 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Clem and B. J. Clark Association of the mSin3A-Histone Deacetylase 1/2 Corepressor Complex with the Mouse Steroidogenic Acute Regulatory Protein Gene Mol. Endocrinol., January 1, 2006; 20(1): 100 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. He, J.-M. Sun, L. Li, and J. R. Davie Differential Intranuclear Organization of Transcription Factors Sp1 and Sp3 Mol. Biol. Cell, September 1, 2005; 16(9): 4073 - 4083. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dunzendorfer, H.-K. Lee, and P. S. Tobias Flow-Dependent Regulation of Endothelial Toll-Like Receptor 2 Expression Through Inhibition of SP1 Activity Circ. Res., October 1, 2004; 95(7): 684 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-M. Ou, K. Chen, and J. C. Shih Dual Functions of Transcription Factors, Transforming Growth Factor-{beta}-inducible Early Gene (TIEG)2 and Sp3, Are Mediated by CACCC Element and Sp1 Sites of Human Monoamine Oxidase (MAO) B Gene J. Biol. Chem., May 14, 2004; 279(20): 21021 - 21028. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Smillie, A. J. Llinas, J. T. P. Ryan, G. D. Kemp, and J. Sommerville Nuclear import and activity of histone deacetylase in Xenopus oocytes is regulated by phosphorylation J. Cell Sci., May 1, 2004; 117(9): 1857 - 1866. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lee, N. Rezai-Zadeh, and E. Seto Negative Regulation of Histone Deacetylase 8 Activity by Cyclic AMP-Dependent Protein Kinase A Mol. Cell. Biol., January 15, 2004; 24(2): 765 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lu, J. Zhou, A. Wiedmer, K. Madden, Y. Yuan, and P. M. Lieberman Chromatin Remodeling of the Kaposi's Sarcoma-Associated Herpesvirus ORF50 Promoter Correlates with Reactivation from Latency J. Virol., November 1, 2003; 77(21): 11425 - 11435. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schuettengruber, E. Simboeck, H. Khier, and C. Seiser Autoregulation of Mouse Histone Deacetylase 1 Expression Mol. Cell. Biol., October 1, 2003; 23(19): 6993 - 7004. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Davie Inhibition of Histone Deacetylase Activity by Butyrate J. Nutr., July 1, 2003; 133(7): 2485S - 2493. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lagger, A. Doetzlhofer, B. Schuettengruber, E. Haidweger, E. Simboeck, J. Tischler, S. Chiocca, G. Suske, H. Rotheneder, E. Wintersberger, et al. The Tumor Suppressor p53 and Histone Deacetylase 1 Are Antagonistic Regulators of the Cyclin-Dependent Kinase Inhibitor p21/WAF1/CIP1 Gene Mol. Cell. Biol., April 15, 2003; 23(8): 2669 - 2679. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Barz, K. Ackermann, G. Dubois, R. Eils, and W. Pyerin Genome-wide expression screens indicate a global role for protein kinase CK2 in chromatin remodeling J. Cell Sci., April 15, 2003; 116(8): 1563 - 1577. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Camarero, A. Nadal, M. J. Barrero, D. Haro, and P. F. Marrero Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site Nucleic Acids Res., March 15, 2003; 31(6): 1693 - 1703. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. THIAGALINGAM, K.-H. CHENG, H. J. LEE, N. MINEVA, A. THIAGALINGAM, and J. F. PONTE Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code Ann. N.Y. Acad. Sci., March 1, 2003; 983(1): 84 - 100. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |